

2697. Pract Radiat Oncol. 2017 Jul - Aug;7(4):e261-e262. doi:
10.1016/j.prro.2016.12.004. Epub 2016 Dec 16.

Beware of deintensification of radiation therapy in patients with p16-positive
oropharynx cancer and rheumatological diseases.

Chera BS(1), Amdur RJ(2), Mendenhall W(2), Zevallos J(3), Hayes DN(4).

Author information: 
(1)Department of Radiation Oncology, University of North Carolina School of
Medicine, Chapel Hill, North Carolina; Lineberger Comprehensive Cancer Center,
University of North Carolina Hospitals, Chapel Hill, North Carolina. Electronic
address: bchera@med.unc.edu.
(2)Department of Radiation Oncology, University of Florida Hospitals,
Gainesville, Florida; Shands Cancer Center, University of Florida Hospitals,
Gainesville, Florida.
(3)Lineberger Comprehensive Cancer Center, University of North Carolina
Hospitals, Chapel Hill, North Carolina; Department of Otolaryngology, Head and
Neck Surgery, University of North Carolina School of Medicine, Chapel Hill, North
Carolina.
(4)Lineberger Comprehensive Cancer Center, University of North Carolina
Hospitals, Chapel Hill, North Carolina; Department of Radiation Oncology,
University of Florida Hospitals, Gainesville, Florida; Division of Hematology
Oncology, Department of Medicine, University of North Carolina School of
Medicine, Chapel Hill, North Carolina.

DOI: 10.1016/j.prro.2016.12.004 
PMID: 28242189  [Indexed for MEDLINE]
